New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

1

McCann Health Managed Markets launches three new customer solutions to help pharma companies meet market access challenges

/in /by

“In a rapidly changing healthcare landscape, new policies combined with significant cost pressures and evolving business models continue to impact drug access and potentially increase restrictions,” said Kim Wishnow-Per, President, MHMM. “We created these proprietary solutions following conversations with our client partners and listening to their specific needs. By designing these three offerings to help solve for their challenges, we are excited to bring new value to our clients and their customers.”

4

Putting the band back together: imre names Christian Bauman as chief creative officer

/in /by

Med Ad News caught up with Bauman ahead of the agency’s announcement, and he was clear in his enthusiasm not only for imre’s creative legacy but also the agency’s culture and people, many of whom Bauman has worked with or known professionally throughout his career. “We’re putting the band back together. Anna [Kotis, imre president] and I have a long-time partnership, going almost 20 years back to when we were partners. Scott Tucker [imre’s chief client officer] and I also worked together.”

6

Precision Value & Health looks at the big picture, rebrands to Precision AQ

/in /by

“We want to introduce Precision AQ as a team of advisors, experts, and creators to sit in the room with our clients to partner, looking at access as a continuum,” President Doug Fulling told Med Ad News. “This has been 10 years in the making. We started the rebrand process six months ago, but the reason that we’re doing this now is we want to simplify our North Star and where we’re going in the marketplace.”

10

Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration

/in /by

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle. This represents a first collaboration of its kind within the pharma and life sciences industries.